Research news

UCLH is part of an important trial researching an investigational vaccine to potentially prevent Mpox (previously known as monkey pox) and small pox. Professor Vincenzo Libri is leading the study at the NIHR UCLH Clinical Research Facility which is aiming to recruit 350 people at sites across the UK.

UCLH and UCL researchers have successfully completed a world-first trial of a therapy designed to restore hearing loss.

A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.

A large study looking at the experiences of people across England after giving birth by Caesarean section has highlighted disparities in outcomes between patients of different ethnic groups.

A new study published last month in The Lancet highlights how carefully planned public health measures including a widespread testing programme prevented spread of Covid-19 during the 2020 Olympics (held in 2021).